Patents by Inventor Aude DE GASSART

Aude DE GASSART has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
    Patent number: 11987631
    Abstract: The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: May 21, 2024
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ AIX MARSEILLE, INSTITUT JEAN PAOLI & IRENE CALMETTE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS
    Inventors: Alemseged Truneh, Daniel Olive, Christine Pasero, Aude De Gassart
  • Anti-BTN3A antibodies and their use in treating cancer or infectious disorders
    Patent number: 11945871
    Abstract: The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
    Type: Grant
    Filed: June 1, 2023
    Date of Patent: April 2, 2024
    Assignees: IMCHECK THERAPEUTICS SAS, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE AIX MARSEILLE, INSTITUT JEAN PAOLI & IRENE CALMETTE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS
    Inventors: Alemseged Truneh, Daniel Olive, Christine Pasero, Aude De Gassart
  • ANTI-BTN3A ANTIBODIES AND THEIR USE IN TREATING CANCER OR INFECTIOUS DISORDERS
    Publication number: 20230322932
    Abstract: The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
    Type: Application
    Filed: June 1, 2023
    Publication date: October 12, 2023
    Inventors: Alemseged TRUNEH, Daniel OLIVE, Christine PASERO, Aude DE GASSART
  • ANTI-BTN3A ANTIBODIES AND THEIR USE IN TREATING CANCER OR INFECTIOUS DISORDERS
    Publication number: 20230272080
    Abstract: The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
    Type: Application
    Filed: September 26, 2022
    Publication date: August 31, 2023
    Inventors: Alemseged TRUNEH, Daniel OLIVE, Christine PASERO, Aude DE GASSART
  • SELECTION OF RESPONDERS FOR ANTI-BTN3A TREATMENT
    Publication number: 20230227558
    Abstract: The present disclosure relates to the pharmaceutical field. More specifically, it relates to methods for treating a tumor in a human subject in need thereof, said method comprising administering a therapeutically efficient amount of an anti-BTN3A antibody which induces the activation of V?9V?2 T cells, in combination with a therapeutically efficient amount of an anti-PD1/PDL1 treatment, wherein said subject is having relapsed or refractory tumors to anti-PD1/PDL1 treatment.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 20, 2023
    Inventors: Emmanuel VALENTIN, Paul FROHNA, Aude DE GASSART
  • ANTI-BTN3A ANTIBODIES AND THEIR USE IN TREATING CANCER OR INFECTIOUS DISORDERS
    Publication number: 20220112289
    Abstract: The present invention relates to humanized antibodies that specifically bind to human BTN3A and their use in treating cancer and infectious disorders.
    Type: Application
    Filed: July 31, 2019
    Publication date: April 14, 2022
    Inventors: Alemseged TRUNEH, Daniel OLIVE, Christine PASERO, Aude DE GASSART